Venture star fall: Theranos out of the blood business, "female jobs" into a laughing stock-the blood test-IT news
According to the Wall Street Journal, blood Diagnostics company Theranos Inc. said it would shut down the company's blood testing facilities, and reduced the number of employees exceeds 40%. Move marks Theranos and its founder, Regal beauty Elizabeth Holmes (Elizabeth Holmes) massive exit of many cheap blood test services provided directly to consumers the core strategy.
Holmes said in a statement published on the company's Web site, the company will again focus on the miniLab platform. Closing and job cuts may help to accelerate the pace of transformation in the closely held company, developing product sold to an outside lab. Holmes was announced in August a new blood test for miniLab equipment, the size of the device and a printer, but has not yet received approval from regulators.
In early June this year, Forbes magazine put it on Holmes's estimates of net worth from $ 4.5 billion last year, down to zero, Theranos founded because she is under several investigation, also accused in court. The magazine said, the real value of the company may only have $ 800 million. "In the case of valuation so low, Holmes shares worthless. ”
Last year, Holmes has been named Forbes "world's youngest self-made female billionaires", her company Theranos are valued at more than $ 9 billion.
Holmes ' experience with legendary, dropped out of Stanford University when she was 19 years old, founded Theranos. After more than 10 years of development, the company "is known as" found dozens of diseases have been developed blood test, needed just gathered from the fingers of one or two drops of blood, one-tenth of the price of traditional detection methods. Holmes himself was called "women's jobs" and many other titles last year as President Obama's entrepreneur ambassadors.
But the medical profession on this question, the Wall Street Journal published an article last year accusing Theranos greatly exaggerated its technological capabilities, claiming that the company most non Theranos equipment for blood tests are run.
创业之星陨落：Theranos退出血液检测业务，"女版乔布斯"成笑柄 - 血液检测 - IT资讯
据《华尔街日报》报道，血液诊断公司Theranos Inc.表示，将关闭该公司的血液检测设施，并将员工人数缩减超过40%。此举标志着Theranos及其创始人、美女富豪伊丽莎白-霍姆斯（Elizabeth Holmes）大举退出直接为消费者提供众多低价验血服务的核心战略。
霍姆斯在该公司网站上发表的一篇声明中称，该公司将重新专注于miniLab平台。关闭设施和裁员可能会帮助这家少数人持股公司加快转型步伐，开发可以向外部实验室销售的产品。霍姆斯8月宣布了一款名为miniLab的新型验血设备，该设备的大小与一台打印机差不多，但还未获得监管机构的批准。
今年6月初，《福布斯》杂志将其对霍姆斯的净资产的估计从去年的45亿美元降至零，因她创办的Theranos正接受多家机构调查，还被告上法庭。该杂志表示，这家公司的实际价值可能只有8亿美元。“在估值如此低的情况下，霍姆斯所持股份基本已一文不值。”
去年《福布斯》曾将霍姆斯评为“全球最年轻的白手起家女富豪”，她的公司Theranos的估值更是达到90亿美元。
霍姆斯的经历极具传奇色彩，她19岁时从斯坦福大学退学，创办了Theranos。经过十几年的发展，该公司“号称”已研发出了发现数十种疾病的血液检测方法，需要的只是从手指采集一到两滴血液，价格只有传统检测方法的十分之一。霍姆斯本人也被冠以“女版乔布斯”等多种称号，去年还成为奥巴马总统的创业者大使。
但医学界对此表示质疑，《华尔街日报》去年刊文，指责Theranos严重夸大其技术能力，声称该公司目前大部分的血液检测都是用非Theranos的设备来运行的。